Multiple inflammation- and signaling-related proteins

The term Multiple inflammation- and signaling-related proteins is a collective descriptor rather than a specific molecular target. It encompasses a vast array of proteins, including cytokines (such as TNF-alpha and various Interleukins), chemokines, protein kinases (such as JAK and MAPK), and transcription factors (such as NF-kappaB) that coordinate the body's response to injury, infection, and environmental stress (Source: Medzhitov, Nature, 2008). These proteins are central to the regulation of the immune system and intracellular communication, and their dysregulation is a hallmark of chronic inflammatory diseases, autoimmune disorders, and many cancers (Source: Furman et al., Nature Medicine, 2019). Because this designation represents a functional network of hundreds of distinct entities with diverse structures, it does not constitute a valid single target for drug development. Instead, therapeutic intervention typically requires the identification and selective inhibition of specific members within this group to achieve efficacy while minimizing systemic side effects (Source: Liu et al., Signal Transduction and Targeted Therapy, 2021). In clinical research, this phrase is often used to describe the broad proteomic or transcriptomic changes observed following treatment with pleiotropic agents like corticosteroids or multi-kinase inhibitors.

Not applicable as this refers to a broad category of proteins rather than a single therapeutic target.